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Self-assembled sorbitol-derived supramolecular 
hydrogels for the controlled encapsulation and release 
of active pharmaceutical ingredients   
Edward J. Howe,a Babatunde O. Okesolaa and David K. Smitha,* 
A simple supramolecular hydrogel based on 1,3:2,4-di(4-
acylhydrazide)benzylidenesorbitol (DBS-CONHNH2), is able 
to extract acid-functionalised anti-inflammatory drugs via 
directed interactions with the self-assembled gel nanofibres.  
Two-component hydrogel-drug hybrid materials can be easily 
formed by mixing and exhibit pH-controlled drug release. 
Gels are fascinating soft materials with potential applications in drug 
delivery.1 In recent years, self-assembled low molecular weight gels 
(LMWGs)2 have begun to emerge as an exciting potential 
technology for this application, with considerable advantages over 
more traditionally-used polymer gels.  LMWGs are of interest as a 
result of the ability to program desired functionality into the gelator 
using basic organic synthesis prior to assembly,3 with the added 
advantages of low gelator loading (<1%) and in situ gelation. 
Active pharmaceutical ingredients (APIs) can be formulated into 
LMWGs using one of two strategies: (a) covalent conjugation and 
(b) physical encapsulation.4  Covalent conjugation of APIs is less 
relevant here, but has included attachment of a wide range of drugs 
for potential enzyme-mediated or hydrolytic release.5  However, 
these prodrug gelators have to be developed a priori for each new 
application. Physical encapsulation of an API effectively forms a 
multi-component gel6 ± the drug may form direct interactions with 
the gelator, or be passively adsorbed within the gel matrix.  
Organogels based on pharmaceutically relevant oils can be used for 
API formulation, 7 for example Naproxen salts form organogels 
capable of controlled API release.8 However, hydrogels offer 
potentially greater biocompatibility.  Many studies have focussed on 
peptide derived gels.9  From the earliest example reported by 
Vegners and co-workers,10 through an influential study from van 
Esch and co-workers, peptide-acid gels were used to formulate 
amine-functionalised APIs ± exhibiting a degree of controlled 
release.11 Many literature reports have focussed on dyes or model 
drugs, but peptide-derived gels have also been used to release 
genuine APIs as varied as doxorubicin and vancomycin.12 Other 
LMWGs based on different building blocks, including G-quartets,13 
imidazolium amphiphiles14 and fatty-acid-modified disaccharides,15 
have been tested for drug delivery.  In attempts to control API 
release, Kim and co-workers demonstrated controlled release of 
AZT from a biotinylated amino acid, with streptavidin modifying 
release rate,16 while Yang and co-workers used a fatty-acid-modified 
amino acid hydrogel with the pH of the receiving medium having a 
small impact on salicylic acid release.17  Other reports have 
controlled gelation using (e.g.) pH,18 photoirradiation,19 or 
crosslinking reactions20 to trigger or inhibit drug release.  
Figure 1.  Structure of gelator (DBS-CONHNH2) and APIs (MSZ, NPX and IBU). 
Recently, we have worked with gelators based on the 1,3:2,4-
dibenzylidene sorbitol (DBS) framework.21  This family of gelators 
is of particular interest, as DBS is widely used in the cosmetics 
industry and considered to have an acceptable toxicity and 
environmental profile.  A recent patent uses DBS to formulate 
pseudoephedrine, preventing easy extraction of the API for use in 
the synthesis of illicit drugs.22 However, DBS generally only gels 
organic solvents.  Importantly, in recent work, we modified the 
DURPDWLFµZLQJV¶RI'%6ZLWKFDUER[\OLFDFLG23 or acyl hydrazide24 
functional groups to generate hydrogels ± significantly expanding 
COMMUNICATION Journal Name 
2 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 2012 
the scope of this family of gelators.  Gels formed by 1,3:2,4-di(4-
acylhydrazide)benzylidene sorbitol (DBS-CONHNH2, Fig. 1) were 
tolerant to a wide pH range (2-11.5) and could adsorb large amounts 
of pollutant dyes.24  As such, we became interested in using this 
gelator for API formulation.  For this preliminary study, we selected 
anti-inflammatory drugs ± 5-amino-salicylic acid (mesalazine, 
MSZ), ibuprofen (IBU), and naproxen (NPX) (Fig. 1).  Enhanced 
formulation of such drugs is of great value.  For example, NPX has 
recently been reported to cause significant problems such as 
ulceration in the stomach.25 Furthermore, MSZ has been formulated 
into gels to enable intestinal release and better treat intestinal 
inflammation, avoiding adverse effects on the stomach.26 
We synthesised DBS-CONHNH2 using our previously disclosed 
method.24 Initial API loading experiments were then carried out with 
MSZ.  We exposed a pre-formed DBS-CONHNH2 hydrogel to a 
supernatant solution of MSZ.  Diffusion of the API allowed simple 
gel loading, which was followed using UV-Vis spectroscopy.  MSZ 
was insufficiently soluble in pure water, but dissolved in acetate 
buffer (pH 4.65) ± on standing the gel under this solution, MSZ was 
removed (Fig. 2).  There was relatively rapid adsorption of MSZ into 
the gel, which was complete in under 24 hours.  Interestingly, ca. 1 
molar equivalent was adsorbed (an excellent API/gelator loading of 
0.32 g/g), and indicating 1:1 DBS-CONHNH2:MSZ interactions.  
Treatment of the adsorption data indicated pseudo-second order 
adsorption kinetics, as commonly observed for this type of process 
(see ESI).27 After loading MSZ, the Tgel value of DBS-CONHNH2 
was depressed by ca 20ºC.  We propose that interactions of gel 
nanofibres with MSZ cause this, possibly because the complex is 
slightly more soluble that DBS-CONHNH2 alone (see below).   
Figure 2.  Uptake of MSZ from solution into DBS-CONHNH2 hydrogel.   
Although this study demonstrated the ability to load a simple 
API into our gel, this formulation method could not be extended to 
our other selected APIs, as their solubility in water was too poor ± 
indeed the logP values of MSZ, NPX and IBU are 1.2,28 3.3429 and 
3.5029 respectively, reflecting increased hydrophobicity as is true for 
many APIs.  We therefore developed an alternative formulation 
approach by mixing API and gelator as solids, and forming gels 
from the two-component mixture.  An equimolar mixture of API and 
gelator were sonicated in water for 15 min, and a heat-cool cycle led 
to gelation for each of MSZ, IBU and NPX.  Interestingly, the APIs 
did not precipitate under these conditions, suggesting they are being 
incorporated into the nanostructure.  However, if the gelator:API 
molar ratio was changed to 1:2, then the (excess) API did precipitate 
out of the hydrosol, supporting the view that there is a stoichiometric 
interaction between acid-functionalised APIs and this gelator.  The 
loading possible with these systems is in the range of 0.32-0.49 g/g 
(API/gelator), depending on the molar mass of the API ± 
significantly higher than many literature values.  The presence of an 
equimolar amount of API enhanced thermal stability (Tgel) in the 
case of NPX and IBU (from 92ºC to >100ºC) but depressed thermal 
stability in the case of MSZ (from 92ºC to 79ºC).  We propose that 
the higher logP values of the former drugs encourage network 
aggregation. 
We then performed rheological studies with a parallel plate 
geometry on gels of DBS-CONHNH2 (10 mM) formed in the 
absence of presence of APIs (also 10 mM) (Table 1 and ESI).  The 
presence of API has some impact on the storage and loss moduli.  
Notably, these moduli increased in the presence of IBU and NPX, 
and decreased in the presence of MSZ.  This is in general agreement 
with the observed Tgel values, and reflects the view that the more 
K\GURSKRELFGUXJV,%8DQG13;UHLQIRUFH WKHµVROLG OLNH¶QDWXUH
of these materials, while the more hydrophilic drug (MSZ) decreases 
the ability of DBS-CONHNH2 to form a solid-like network.  
Table 1.  Rheological Performance of DBS-CONHNH2 (10 mM) hydrogels 
in the presence and absence of APIs (10 mM). 
API 0D[*¶N3D 0D[*¶¶N3D 
None 14.5 2.6 
MSZ 10.2 1.8 
IBU 19.6 4.1 
NPX 33.0 5.6 
Figure 3.  SEM images of dried xerogels formed by DBS-CONHNH2 in the 
presence of: (top left) no additive, (top right) IBU, (bottom left) MSZ, (bottom 
right) NPX. [Scale bar; 100 nm] 
We then studied these API-gel hybrids using scanning electron 
microscopy (SEM, Fig. 3).  Although this technique images dried 
xerogels rather than solvated systems, it is effective for 
comparability studies in closely related systems.  The xerogel of 
DBS-CONHNH2 exhibited extended and intertwined bundles of 
fibres having a diameter of ca. 43 nm.  In the presence of all APIs, 
nanoscale fibres were once again observed, demonstrating that the 
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API does not inhibit gel assembly.  Furthermore, no microcrystals 
(which may have been associated with unincorporated API) were 
observed, supportive of specific interactions between APIs and 
gelator fibres.  In the presence of APIs the diameters of the fibre 
bundles are ca. 36 nm, 29 nm and 29 nm respectively for the 
hydrogels with IBU, NPX and MSZ.  It would therefore appear that 
the interaction of the API with the nanofibres somewhat limits the 
ability of the fibres to bundle. 
Infra-red (IR) spectroscopy is a powerful way of monitoring 
interactions within such materials.  Interestingly, the presence of the 
drug molecules shifted the N-H stretch of DBS-CONHNH2 from 
3194 cm-1 to lower wavenumbers by up to 16 cm-1.  This is 
consistent with the formation of interactions between this functional 
group and APIs.  The O-H peak of sorbitol shifted by ca. 20 cm-1 to 
longer wavelength, consistent with possible involvement of this 
hydrogen bonding group.  The C=O peak was less affected (max 
shift 6 cm-1) and the aromatic C=C stretches and the C-O stretches 
were completely unchanged, which would appear to rule out SS or 
solvophobic interactions between the gel fibres and these APIs.  As 
such, IR supports specific interactions between the polar NH2/OH 
units of the gelator and the  API carboxylic acid.  
For NPX-loaded gels, the unique chromophore of the 
naphthalene, distinct from DBS-CONHNH2, meant we carried out 
some additional spectroscopic experiments.  A CD band associated 
with chiral gelator DBS-CONHNH2 at ca. 275 nm only emerges on 
self-assembly ± this band can be attributed to the stacking of the 
DURPDWLFµZLQJV¶RIWKHJHODWRULnto a chiral nanostructure (see supp. 
info.).  This broad CD band was shifted slightly in the presence of 
NPX but maintained its key features.  This would suggest the view 
that the API does not significantly disrupt chiral stacking of the DBS 
molecules and binds to the periphery of the nanofibres. Interestingly, 
a signal associated with NPX was also observed ± a positive band at 
ca 310 nm and a negative band at ca 335 nm, demonstrating that this 
API is homogeneously incorporated into the gel in such a way that 
its chiral signature can be visually observed.   
By following the evolution of the DBS-CONHNH2 CD band 
over time, it is possible to gain insight into the kinetics of gel fibre 
growth.  This can be fitted to the Avrami model which offers 
insights into the dimensionality of fibre growth (see ESI for 
details).30  For the gelator alone (at 2.5 mM), the Avrami coefficient 
was 1.18, whereas in the presence of NPX, it was 1.08.  In both 
cases the gelation was fast and was effectively complete in < 5 miin.  
This would suggest that in both cases fibre formation is primarily 
one-dimensional, as supported by SEM imaging. 
Fluorescence spectroscopy using an excitation wavelength of 
272 nm, and comparing emission spectra of DBS-CONHNH2 in the 
absence and presence of NPX was informative (Fig. 4).  For the 
gelator alone, there was an emission band at 340 nm.  For NPX, an 
emission band at 360 nm was observed.  For the combination of 
gelator and NPX, the gelator emission band at 340 nm disappeared, 
while the band at 360 nm associated with NPX increased in 
intensity.  This effect was most marked at a gelator:API molar ratio 
of 1:1 (see ESI for full data).  Although these experiments are 
performed at relatively high concentration, the results suggest energy 
transfer from gelator to NPX can take place within the gel, leading to 
loss of the gelator emission and enhancement of that of NPX.  This 
can be mediated by close interactions between the chromophores of 
the individual components ± consistent with a model in which NPX 
is bound in close proximity to the gelator aromatic rings. 
Figure 4.  Emission spectra of a) DBS-CONHNH2, b) NPX and c) equimolar mixture 
of DBS-CONHNH2 and NPX. 
The release of APIs was investigated, and NPX could easily be 
followed because of its longer wavelength UV-Vis absorption.  At 
pH 7 and incubated at 37ºC, only 33% of the drug was released over 
24 hours, whereas at pH 8 this rose to 100% (Fig. 5).  We suggest 
that deprotonation of the API assists its release from the gel network 
under the conditions of higher pH.  Using pH-adjusted water at pH 8, 
rather than buffered water slowed the release rate, explained by API 
release effectively lowering the pH of the receiving solution in this 
case.  The release of MSZ and IBU could not be followed in this 
assay owing to inconsistent release profiles and difficulties with 
calibration/solubility.  We suggest that the lower solubility of IBU 
limits release in this assay ± although we anticipate release of this 
API in the presence of apolar biomembranes would still be possible. 
Figure 5.  Release profiles of NPX from DBS-CONHNH2 hydrogel into a 
supernatant aqueous solution under different conditions of pH control. 
These DBS-CONHNH2 gels are therefore ideal for release of 
NPX at slightly elevated (e.g. intestinal) pH values.  Given the 
recently disclosed adverse effects of NPX in the stomach,25 this is a 
significant observation.  However, it should be noted that in very 
low pH  conditions (<pH 2) the gels became less stable ± which may 
limit direct oral application.  However, problems such as this can be 
solved by encapsulation within an enteric coated capsule.  We would 
also suggest that co-formulation with a more stable gelator to form a 
hybrid system may help solve this problem.31 These gels may also be 
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useful for slow-release delivery, with the gel forming in situ after 
(e.g.) subcutaneous injection.  Importantly, DBS is widely applied in 
cosmetic products,21 and nanoscale acyl hydrazides have also been 
demonstrated to have good biological compatibility,32 which bodes 
well for the potential relevance of this technology. 
In summary, this preliminary communication reports a simple 
gelation system which encapsulates anti-inflammatory APIs as a 
consequence of direct 1:1 API-gelator interactions in a novel and 
interesting two-component gelation system.  The adsorption and 
release of the APIs is therefore not simply passive.  Furthermore, the 
hybrid co-assembled systems exhibit strongly pH-controlled, bio-
relevant release of NPX, with significantly greater levels of release 
at pH 8 (intestinal pH) than 7.  Self-assembled gels are small-
molecule drug-like systems which, in principle, have well-
established routes to clinical application, and we propose 
formulation systems such as these have considerable potential. 
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financial support of this research. 
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